0001564590-19-019629.txt : 20190516 0001564590-19-019629.hdr.sgml : 20190516 20190516161013 ACCESSION NUMBER: 0001564590-19-019629 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190510 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZIMMER BIOMET HOLDINGS, INC. CENTRAL INDEX KEY: 0001136869 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 134151777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16407 FILM NUMBER: 19832322 BUSINESS ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 BUSINESS PHONE: 5742676131 MAIL ADDRESS: STREET 1: 345 EAST MAIN STREET CITY: WARSAW STATE: IN ZIP: 46580 FORMER COMPANY: FORMER CONFORMED NAME: ZIMMER HOLDINGS INC DATE OF NAME CHANGE: 20010315 8-K 1 zbh-8k_20190510.htm 8-K zbh-8k_20190510.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 10, 2019

 

 

ZIMMER BIOMET HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-16407

13-4151777

(State or other jurisdiction

(Commission

(IRS Employer

of incorporation)

File Number)

Identification No.)

 

345 East Main Street

Warsaw, Indiana 46580

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:  (574) 267-6131

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

ZBH

New York Stock Exchange

1.414% Notes due 2022

ZBH 22A

New York Stock Exchange

2.425% Notes due 2026

ZBH 26

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)  

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

 


Item 5.07Submission of Matters to a Vote of Security Holders

 

Zimmer Biomet Holdings, Inc. (the “Company”) held its annual meeting of shareholders on May 10, 2019.  Shareholders took the following actions:

 

•

elected eleven (11) directors for one-year terms ending at the 2020 annual meeting of shareholders (Proposal 1);

 

•

ratified the Audit Committee’s appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2019 (Proposal 2); and

 

•

approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s proxy statement (Proposal 3).

 

The vote tabulation for each proposal follows:

 

Proposal 1 – Election of Directors

 

Nominee

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

Christopher B. Begley

 

165,607,196

 

1,268,582

 

160,092

 

13,842,790

 

Betsy J. Bernard

 

165,902,379

 

985,309

 

148,182

 

13,842,790

 

Gail K. Boudreaux

 

165,845,800

 

1,044,495

 

145,575

 

13,842,790

 

Michael J. Farrell

 

165,151,019

 

1,727,895

 

156,956

 

13,842,790

 

Larry C. Glasscock

 

162,900,972

 

3,959,903

 

174,995

 

13,842,790

 

Robert A. Hagemann

 

165,023,230

 

1,842,852

 

169,788

 

13,842,790

 

Bryan C. Hanson

 

166,382,851

 

489,302

 

163,717

 

13,842,790

 

Arthur J. Higgins

 

129,060,779

 

37,805,037

 

170,054

 

13,842,790

 

Maria Teresa Hilado

 

166,433,590

 

456,620

 

145,660

 

13,842,790

 

Syed Jafry

 

166,382,455

 

496,016

 

157,399

 

13,842,790

 

Michael W. Michelson

 

165,596,990

 

1,272,329

 

166,551

 

13,842,790

 

 

Proposal 2 – Ratification of the Appointment of the Independent Registered Public Accounting Firm

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

178,045,239

 

2,686,859

 

146,562

 

0

 

 

Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation (“Say on Pay”)

 

For

 

Against

 

Abstained

 

Broker Non-Votes

 

100,059,296

 

60,202,489

 

6,774,085

 

13,842,790

 

 

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date:  May 16, 2019

 

ZIMMER BIOMET HOLDINGS, INC.

 

 

 

By:/s/ Chad F. Phipps

Name:   Chad F. Phipps

Title:     Senior Vice President, General Counsel
              and Secretary